Today’s top gainers include the company Amgen Inc. (NASDAQ:AMGN) which is in the industry Biotechnology, gaining 1.38% today. In the last week its performance is 3.93%, and 2.31% for the past quarter. Currently, Amgen Inc., AMGN has a target price of 183.88, so today’s gain of 1.38% is a significant step towards its target price. The GAP today is therefore 0.92%.
Amgen Inc. (NASDAQ:AMGN), has a market cap of 122543.22, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.30%.
At the current price of 162.74, it has a dividend yield of 2.46%, and its target price is 183.88. This is with a profit margin of 32.60%, and total debt/equity of 1.2. Amgen Inc. (NASDAQ:AMGN) has a P/E of 17.22, as well as a forward P/E of 13.36.
With a current EPS of 9.45, and a forecasted EPS growth for next year at 8.94%,Amgen Inc. (NASDAQ:AMGN) has had a EPS growth for the past five years at 13.60%. For the next five years EPS growth is projected to be 8.37%.
Performance for the year is 3.81%. Since its IPO date on 9/7/1984, the total performance to date is 1.61%.
Volume today for Amgen Inc. (NASDAQ:AMGN), is 2443800, while its average volume is 2814.03. Whilst the total gain today was 1.38%, it did have a day high of 0.05%.
Volatility for this week has been at 1.71%, and 1.73% for the month. The 52-week low for Amgen Inc., AMGN has been 27.44%, while the 52-week-high has reached -8.39%.
Looking at its return of investments, which is 12.50%, and its return on assets is 10.00%. Amgen Inc. (NASDAQ:AMGN) has an operating margin of 39.90%. With a sales growth of 9.80% quarter over quarter. Bearing in mind that Amgen Inc., AMGN is in the sector Healthcare, its long-term debt/equity is 1.12, and has a current ratio of 5 and 4.7 for quick ratio.
So what is the value of Amgen Inc.? Well its PEG is 2.06, and the P/S is 5.53, along with a P/B of 4.27. Meanwhile it has a p/cash of 3.53.